Cargando…

Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease

BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Brockmeyer, Maximilian, Wies, Emilia, Joerges, Jamuna, Sommer, Jana, Borgmann, Sandra Olivia, Chernyak, Nadja, Lin, Yingfeng, Parco, Claudio, Schulze, Volker, Heinen, Yvonne, Kelm, Malte, Icks, Andrea, Perings, Stefan, Wolff, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933116/
https://www.ncbi.nlm.nih.gov/pubmed/36448416
http://dx.doi.org/10.1002/clc.23948
_version_ 1784889605336596480
author Brockmeyer, Maximilian
Wies, Emilia
Joerges, Jamuna
Sommer, Jana
Borgmann, Sandra Olivia
Chernyak, Nadja
Lin, Yingfeng
Parco, Claudio
Schulze, Volker
Heinen, Yvonne
Kelm, Malte
Icks, Andrea
Perings, Stefan
Wolff, Georg
author_facet Brockmeyer, Maximilian
Wies, Emilia
Joerges, Jamuna
Sommer, Jana
Borgmann, Sandra Olivia
Chernyak, Nadja
Lin, Yingfeng
Parco, Claudio
Schulze, Volker
Heinen, Yvonne
Kelm, Malte
Icks, Andrea
Perings, Stefan
Wolff, Georg
author_sort Brockmeyer, Maximilian
collection PubMed
description BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) treatment goals, subjective level of information, and information needs in very high‐risk patients with ASCVD. METHODS: ASCVD patients (n = 210; 75 ± 9 years; 71.4% male; 89.5% coronary disease) with DM (96.7% type 2) completed a questionnaire assessing knowledge of HbA1c and LDL‐C treatment goals and subjective level of information and information needs on disease‐related topics of DM and ASCVD. Serum LDL‐C and HbA1c were measured. RESULTS: HbA1c goal (<7.0% in 60.6%) was attained more frequently than LDL‐C goal (<70 mg/dl in 39.9%; p < .01). Significantly more participants named the correct goal for HbA1c compared to LDL‐C (52.9% vs. 2.4%; p < .01). Subjective levels of information were higher and information needs were lower for DM than for ASCVD (p < .01 for all topics). No associations of knowledge of treatment goals and level of information with the attainment of treatment goals for HbA1c and LDL‐C were found. However, in multivariate regression, higher levels of education were associated with knowledge of treatment goals (HbA1c: odds ratio [OR] 1.32, 95% confidence interval [CI] 1.01–1.72, p = .04; LDL‐C: OR 2.32, 95% CI 1.07–5.03; p = .03). CONCLUSION: In very high‐risk patients with ASCVD, a deficit of knowledge of treatment goals to control dyslipidemia exists when compared to DM, patients felt significantly better informed for topics of DM than for ASCVD and display higher information needs for topics of ASCVD.
format Online
Article
Text
id pubmed-9933116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99331162023-02-17 Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease Brockmeyer, Maximilian Wies, Emilia Joerges, Jamuna Sommer, Jana Borgmann, Sandra Olivia Chernyak, Nadja Lin, Yingfeng Parco, Claudio Schulze, Volker Heinen, Yvonne Kelm, Malte Icks, Andrea Perings, Stefan Wolff, Georg Clin Cardiol Clinical Trial Result BACKGROUND/HYPOTHESIS: Risk factor control of diabetes mellitus (DM) and especially dyslipidemia remains unsatisfactory in patients with atherosclerotic cardiovascular disease (ASCVD). We aimed to analyze the knowledge of low‐density lipoprotein cholesterol (LDL‐C) and glycated hemoglobin (HbA1c) treatment goals, subjective level of information, and information needs in very high‐risk patients with ASCVD. METHODS: ASCVD patients (n = 210; 75 ± 9 years; 71.4% male; 89.5% coronary disease) with DM (96.7% type 2) completed a questionnaire assessing knowledge of HbA1c and LDL‐C treatment goals and subjective level of information and information needs on disease‐related topics of DM and ASCVD. Serum LDL‐C and HbA1c were measured. RESULTS: HbA1c goal (<7.0% in 60.6%) was attained more frequently than LDL‐C goal (<70 mg/dl in 39.9%; p < .01). Significantly more participants named the correct goal for HbA1c compared to LDL‐C (52.9% vs. 2.4%; p < .01). Subjective levels of information were higher and information needs were lower for DM than for ASCVD (p < .01 for all topics). No associations of knowledge of treatment goals and level of information with the attainment of treatment goals for HbA1c and LDL‐C were found. However, in multivariate regression, higher levels of education were associated with knowledge of treatment goals (HbA1c: odds ratio [OR] 1.32, 95% confidence interval [CI] 1.01–1.72, p = .04; LDL‐C: OR 2.32, 95% CI 1.07–5.03; p = .03). CONCLUSION: In very high‐risk patients with ASCVD, a deficit of knowledge of treatment goals to control dyslipidemia exists when compared to DM, patients felt significantly better informed for topics of DM than for ASCVD and display higher information needs for topics of ASCVD. John Wiley and Sons Inc. 2022-11-30 /pmc/articles/PMC9933116/ /pubmed/36448416 http://dx.doi.org/10.1002/clc.23948 Text en © 2022 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Trial Result
Brockmeyer, Maximilian
Wies, Emilia
Joerges, Jamuna
Sommer, Jana
Borgmann, Sandra Olivia
Chernyak, Nadja
Lin, Yingfeng
Parco, Claudio
Schulze, Volker
Heinen, Yvonne
Kelm, Malte
Icks, Andrea
Perings, Stefan
Wolff, Georg
Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
title Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
title_full Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
title_fullStr Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
title_full_unstemmed Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
title_short Knowledge of HbA1c and LDL‐C treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
title_sort knowledge of hba1c and ldl‐c treatment goals, subjective level of disease‐related information and information needs in patients with atherosclerotic cardiovascular disease
topic Clinical Trial Result
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933116/
https://www.ncbi.nlm.nih.gov/pubmed/36448416
http://dx.doi.org/10.1002/clc.23948
work_keys_str_mv AT brockmeyermaximilian knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT wiesemilia knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT joergesjamuna knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT sommerjana knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT borgmannsandraolivia knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT chernyaknadja knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT linyingfeng knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT parcoclaudio knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT schulzevolker knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT heinenyvonne knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT kelmmalte knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT icksandrea knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT peringsstefan knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease
AT wolffgeorg knowledgeofhba1candldlctreatmentgoalssubjectivelevelofdiseaserelatedinformationandinformationneedsinpatientswithatheroscleroticcardiovasculardisease